Member Info for Prion25

Https://www.bbc.co.uk/news/articles/c23ljy4z05mo

As discussed before the power consumption of data centres and Ceres tech as the solution to this critical infrastructure

PM was the "front man "to communicate to the scientific community at various conferences that the granular data obtained from the P3 botch up was enough to demonstrate that sng001 still had potential in a very vulnerable sub group. Nobody was swayed and I think PM the front man has now become the fall guy for the lack of progress since P3

130 clean energy ,Wind , Solar and Tidal contracts handed out by Ed Windbag "new jobs "mostly to Danish company no mention yet of Hydrogen The Sunak Boris GoV made a big commitment to Hydrogen when the wind does not blow or the sun does not shine

Feels like desperation ,damage limitation and praying for a life line before AGM . Very sad news

Complete response (CR): The tumor disappears

Partial response (PR): The tumor shrinks

Stable disease (SD): The tumor stays the same

Progressive disease (PD): The tumor gets bigger

The article reminded me about RECIST 1:1 criteria above and it could be the longer the trial goes on the more likely hood of (CR) / improved outcomes

Doxrubicin when not in combination the efficacy rates of doxorubicin treatment can vary depending on the type of cancer for example for patients with advanced soft tissue sarcoma, doxorubicin-based chemotherapy has shown response rates of approximately 25%. The median progression-free survival is around 4-7 months, and overall survival ranges from 12-17 months and you have to factor in serious the toxicity effects of Dox . So the trials results we are expecting the bar in my opinion has been set relatively low .AVA6000 prodrug will reduce toxicity and improve efficacy so there so much to be optimistic about and the potential of new warheads and combination therapies

Good find DSFLAT new research tools on brain mapping being developed - lets hope that Sulforaphane intervention will be proved beneficial more rapidly through clinical trials

Https://www.mskcc.org/cancer-care/clinical-trials/22-428

https://www.ft.com/content/cc3e83b4-79eb-46fa-944f-7b2fc909051a

Just responding to The FT article discussing the most difficult cancers to treat namely pancreatic cancer and that the phase 1a trial may include patients with pancreatic cancer .Hoping for the best outcome for all the suffers of this dreadful disease .

Thanks BV

At a glance very interesting article ,food for thought .

In The FT article “ cracking cancer” has anyone got a subscription thanks

Just seen the second RNS that is a positive signal GLA

I am no expert and can only give my guess/opinion .Spreadex also have a holding in my Ceres Power investment .Seems they may target volatile SP companies especially companies where the price may drop suddenly and recover to facilitate spread bets Ceres even with good news the share price is a frustrating yoyo

21-Aug-24 08:03:16 192.3899 78,940 Buy* 151.87k

Somebody not paying attention to you !

From my research of a complicated subject .

Regarding the timing of administration, clopidogrel is usually given as soon as possible after an ischemic stroke or TIA, once hemorrhagic stroke has been ruled out through imaging. Early administration can help reduce the risk of subsequent strokes.

NICE have already stated the Genedrive is the the preferred POC test when laboratory tests are not available .Conversely the Cube laboratory test will be used if the Genedrive POC test is not available .POC and rapid result in the most serious stroke cases will attract sales imo

Thanks Hurst

https://www.launchdiagnostics.com/product/bosphore-monkeypox-detection-kit-v1/

Wes Streeting will be announcing his masterstroke on savings within the NHS soon !

Https://www.denso.com/global/en/about-us/at-a-glance/

Great news more details to follow

Thanks for sharing MrP

I posted this on the 17th of June on data centres and the consequence of the massive growth of AI

"Watching a BBC 24 hours news talking business programme they were discussing artificial intelligence data centres and their massive energy consumption and carbon footprint The energy and footprint was described as equivalent to commercial Airlines. The AI data centre growth will be exponential and clean power will be paramount Ceres have already mentioned on their website opportunities to supply commercial energy such as data centres You would think there are great opportunities out there?"

Exciting news just landed for ITM .I am no expert on the hydrogen economy but it must be good news all round for the future growth globally of this sector GLA